At Virtru, we have an ambitious mission: to unlock the power of data by helping create a world where it is always under your control. Everywhere. \n\nOur flexible, easy to use, and trusted privacy technologies govern access to data throughout its full lifecycle – from creation through sharing, storage, analysis, and action. Virtru’s portfolio of products include:\n\nData privacy solutions that transparently integrate into commonly used applications, such as email and file sharing, providing automatic security and total control. Plus, a set of privacy engineering tools for Developers that can be easily and seamlessly integrated into any application, connected device, and infrastructure. \n\nFor more information, visit www.virtru.com or follow us on Twitter at @virtruprivacy.

MaxCyte is a global cell-based medicines and life sciences company applying its patented cell engineering technology to help patients with high unmet medical needs in a broad range of conditions. MaxCyte is developing novel CARMA therapies for its own pipeline. CARMA is MaxCyte's mRNA-based proprietary platform for autologous cell therapy. In addition, through its core business, the Company leverages its Flow Electroporation® Technology to enable its partners across the biopharmaceutical industry to advance the development of innovative medicines, particularly in cell therapy, including gene editing and immuno-oncology. The Company has placed its cutting-edge flow electroporation instruments worldwide, including with nine of the top 10 global biopharmaceutical companies, and has more than 55 partnered program licenses in cell therapy including more than 25 licensed for clinical use. With its robust delivery technology, MaxCyte helps its partners to unlock the full potential of their products. For more information, visit www.maxcyte.com.